Jing Wei

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Weijia Kong, Jing Wei, Parveen Abidi et al. · Nature Medicine · 2004 · 1.4K citations

Oxysterol, Biochemistry, Pharmacology +5

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

Hao Zhang, Jing Wei, Rong Xue et al. · Metabolism · 2009 · 425 citations

Metabolic Syndrome, Diabetes Management, Health Sciences +9

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Lei Shu, Changming Niu, Ruyou Li et al. · Stem Cell Research & Therapy · 2020 · 306 citations · Full text

Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression

Weijia Kong, Hao Zhang, Danqing Song et al. · Metabolism · 2008 · 261 citations

Insulin Resistance, Metabolic Syndrome, Insulin Signaling +13

Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response.

Yi Zheng, Bo Gao, Li Ye et al. · PubMed · 2005 · 107 citations